Common metabolic inhibitor has potential as nasal spray-preventative for Covid
New research is developing a new formulation of a common metabolic inhibitor (niclosamide) that could turn it into a promising prophylactic/preventative nasal spray and early treatment throat spray for Covid-19.
Read more